重组人黑色素瘤抑制活性蛋白(MIA)

特别提示：包括重组人黑色素瘤抑制活性蛋白(MIA)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人黑色素瘤抑制活性蛋白(MIA)
英文名称：Recombinant Human Melanoma Inhibitory Activity Protein
产品货号：JN1943
产品规格：10μg|50μg|500μg|1mg

本品由我们的大肠杆菌表达系统制备而成，目的基因编码的Gly25-Gln131在C端含有His标签。

MIA质量控制：＞95%(还原性SDS-PAGE)

MIA制剂：冻干品

MIA保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

MIA复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于MIA：
Melanoma Inhibitory Activity Protein (MIA) is an autocrine growth regulatory protein secreted from chondrocytes and malignant melanoma cells, which was the first discovered member of a family of secreted cytokines termed the MIA/OTOR family. The four known members of this family: MIA, MIA2, OTOR and TANGO each contain a Src homology-3 (SH3)-like domain. MIA acts as a potent tumor cell growth inhibitor for malignant melanoma cells and some other neuroectodermal tumors, including gliomas, in an autocrine fashion and promotes melanoma metastasis by binding competitively to fibronectin and laminin in a manner that results in melanoma cell detachment from the extracellular matrix in vivo. The protein MIA has been shown to represent a very sensitive and specific serum marker for systemic malignant melanoma that might be useful for staging of primary melanomas, detection of progression from localized to metastatic disease during follow-up, and monitoring therapy of advanced melanomas. Elevated levels of MIA may represent a clinically useful marker for diagnosis of melanoma metastasis as well as a potential marker for rheumatoid arthritis.

除了重组人黑色素瘤抑制活性蛋白(MIA),，我公司还供应以下相关产品：
 

货号	名称	规格
JN0274	重组小鼠转换生长因子β1(TGF-β1)	10μg|50μg|500μg|1mg
JN0300	重组人趋化因子CXCL1(GROα)	10μg|50μg|500μg|1mg
JN0316	重组人趋化因子CCL8(MCP-2)	10μg|50μg|500μg|1mg
JN0401	重组人白介素IL-12β	10μg|50μg|500μg|1mg
JN0440	重组兔TNF-α(TNFSF2)	10μg|50μg|500μg|1mg
JN1911	重组人BCL2L2(Bc1-w)	10μg|50μg|500μg|1mg
JN0534	重组人干扰素α/β受体1(IFNAR1)	10μg|50μg|500μg|1mg
JN0614	重组人肺表面活性物质相关蛋白D(SP-D)	10μg|50μg|500μg|1mg
JN0732	重组人碳酸*酶11(CA11)	10μg|50μg|500μg|1mg
JN0787	重组人FLRT3	10μg|50μg|500μg|1mg
JN0901	重组人锌指BED结构域结合蛋白1(ZBED1)	10μg|50μg|500μg|1mg
JN0957	重组人SMAD4(母抗Dpp小同源物4)	10μg|50μg|500μg|1mg
JN1132	重组人EphB1	10μg|50μg|500μg|1mg
JN1155	重组人含V-set和Ig结构域蛋白4(VSIG4)(C端带Fc标签)	10μg|50μg|500μg|1mg
JN1338	重组人S100A8(S100A9 Heterodimer)	10μg|50μg|500μg|1mg
JN1354	重组小鼠Dtk	10μg|50μg|500μg|1mg
JN1540	重组小鼠补体C3a	10μg|50μg|500μg|1mg
JN1600	重组人Osteocrin(Musclin)	10μg|50μg|500μg|1mg
JN1608	重组人胱抑素C(cys-C)(CST3)	10μg|50μg|500μg|1mg
JN1618	重组小鼠DNAM-1(CD226)	10μg|50μg|500μg|1mg
JN1669	重组人Serpin A12(丝氨酸蛋白酶抑制剂A12)	10μg|50μg|500μg|1mg
ZN1613	人CYR61重组蛋白	100ng
ZN1659	人IL4重组蛋白	100ng
ZN1718	人TIE-2重组蛋白	100ng
ZN1819	大鼠VEGF重组蛋白	100ng